These findings reinforce the notion that metabolic dysfunction, and obesity in particular, is not merely a comorbidity but an active modifier of PsA pathophysiology and treatment outcomes
Both medications have similar side effects, mainly gastrointestinal, with a rare risk of severe issues like thyroid tumors
This reduces the frequency of cravings, particularly for high-calorie, unhealthy foods, making it easier to adopt healthier eating habits and stick to a nutritious diet
Moreover, studies show consistent effects on insulin dynamics, lipid handling, and energy regulation in controlled research settings
However, coverage for their weight-loss counterparts, Wegovy and Zepbound, is less consistent